Repurposed Therapies, New Compounds to Be Tested to Block Brain Inflammation in Parkinson’s
Researchers in Australia are planning to test therapies already being used in other inflammatory conditions, as well as new compounds,…
Articles by José Lopes, PhD
Osteonectin Protein May Play Role in Parkinson’s, Other Neurodegenerative Diseases
A protein called osteonectin may be implicated in Parkinson’s and other neurodegenerative diseases, according to a computer-based analysis. The…
Apathy and Depression Linked to Sleep Disorder in Parkinson’s Patients, Study Finds
Symptoms of apathy and depression are more frequent and severe in Parkinson’s patients with rapid eye movement sleep…
Emapunil Holds Promise as Parkinson’s Treatment, Mouse Study Results Show
A compound called emapunil prevented the characteristic loss of nerve cells associated with Parkinson’s disease, lowered levels of dopamine,…
Parkinson’s Patients on DBS Aren’t More Impulsive, Study Finds
Parkinson’s patients treated with deep brain stimulation (DBS) are not more impulsive than other patients or healthy people toward…
Group Therapeutic Singing via Telemedicine Improved Respiratory Function of Parkinson’s Patients in Rural Iowa, Study Finds
Parkinson’s disease patients living in rural areas in Iowa show improved respiratory function with group therapeutic singing delivered via telemedicine,…
Wives of Parkinson’s Patients are More Impaired in Postural Stability from Caretaking, Study Finds
Wives who take care of husbands with Parkinson’s disease have greater impairments in their stability while standing than housewives…
Deep Brain Stimulation System Aimed at More Precise, Safer Targeting in Parkinson’s Patients
A tool called Vercise Cartesia Directional Lead is intended to provide more precise deep brain stimulation (DBS) treatment…
Plasma Infusions from Young Donors Carry Risks, No Benefit, FDA Warns
The U.S. Food and Drug Administration (FDA) is warning consumers, physicians, and health care providers that infusions of plasma from…
Gene Variations Early in Life May Explain Vulnerability to Neurodegenerative Diseases
Naturally occurring gene variations in brain cells may explain why dopamine-producing neurons are the first to die in people with…